Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lallemant

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure?James McIntyre, Marc Lallemant
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 19, 2006
Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an updateTim R Cressey, Marc Lallemant
Antiviral Therapy|May 12, 2004
Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infantsSukon Prasitwattanaseree, Marc Lallemant, Dominique Costagliola, et al.
Children (Basel, Switzerland)|April 23, 2022
Systems Challenges in Accessing Medicines among Children under Thailand's Universal Health Coverage: A Qualitative Study of a Provincial Public Hospital NetworkRangsan Daojorn, Puckwipa Suwannaprom, Siritree Suttajit, et al.
The Pediatric Infectious Disease Journal|December 10, 2019
Acceptability and Feasibility of Using Raltegravir Oral Granules for the Treatment of Neonates in a Low-resource SettingMoherndran Archary, Brian Zanoni, Marc Lallemant, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patientsTim R Cressey, Sawitree Nangola, Yardpiroon Tawon, et al.
Children (Basel, Switzerland)|March 25, 2022
Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern ThailandPrangthong Tiengkate, Marc Lallemant, Pimlak Charoenkwan, et al.
Frontiers in Pharmacology|August 2, 2023
Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations projectElisa Barbieri, Chiara Minotti, Sara Cavagnis, et al.
The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.
BMJ Open|April 1, 2017
Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluationAriadna Nebot Giralt, Christiana Nöstlinger, Janice Lee, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Current Opinion in HIV and AIDS|April 18, 2009
The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure?James McIntyre, Marc Lallemant
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 19, 2006
Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an updateTim R Cressey, Marc Lallemant
Antiviral Therapy|May 12, 2004
Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infantsSukon Prasitwattanaseree, Marc Lallemant, Dominique Costagliola, et al.
Children (Basel, Switzerland)|April 23, 2022
Systems Challenges in Accessing Medicines among Children under Thailand's Universal Health Coverage: A Qualitative Study of a Provincial Public Hospital NetworkRangsan Daojorn, Puckwipa Suwannaprom, Siritree Suttajit, et al.
The Pediatric Infectious Disease Journal|December 10, 2019
Acceptability and Feasibility of Using Raltegravir Oral Granules for the Treatment of Neonates in a Low-resource SettingMoherndran Archary, Brian Zanoni, Marc Lallemant, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patientsTim R Cressey, Sawitree Nangola, Yardpiroon Tawon, et al.
Children (Basel, Switzerland)|March 25, 2022
Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern ThailandPrangthong Tiengkate, Marc Lallemant, Pimlak Charoenkwan, et al.
Frontiers in Pharmacology|August 2, 2023
Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations projectElisa Barbieri, Chiara Minotti, Sara Cavagnis, et al.
The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.
BMJ Open|April 1, 2017
Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluationAriadna Nebot Giralt, Christiana Nöstlinger, Janice Lee, et al.
Pageof 10